News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
826,152 Results
Type
Article (85368)
Company Profile (683)
Press Release (740101)
Section
Business (232010)
Career Advice (4093)
Deals (39629)
Drug Delivery (108)
Drug Development (90542)
Employer Resources (192)
FDA (17926)
Job Trends (17254)
News (394988)
Policy (39600)
Tag
Academia (2974)
Africa (1264)
Alliances (56376)
Alzheimer's disease (1264)
Approvals (17839)
Arizona (214)
Artificial intelligence (105)
Asia (49085)
Australia (8640)
Bankruptcy (393)
Best Places to Work (12334)
Biotechnology (472)
Breast cancer (83)
C2C Services and Suppliers (95111)
California (2321)
Canada (1037)
Cancer (697)
Career advice (3500)
Cell therapy (179)
China (177)
Clinical research (70736)
Collaboration (219)
Colorado (98)
Compensation (130)
Connecticut (103)
COVID-19 (2768)
Cystic fibrosis (83)
Data (491)
Diabetes (110)
Diagnostics (6543)
Drug pricing (96)
Earnings (93598)
Employer resources (162)
Europe (112299)
Events (125350)
Executive appointments (201)
FDA (18249)
Florida (325)
Funding (201)
Gene therapy (124)
GLP-1 (638)
Government (5027)
Healthcare (20663)
Hotbed/Location (534575)
Illinois (346)
Indiana (171)
Infectious disease (2817)
Inflammatory bowel disease (105)
Interviews (805)
IPO (17519)
Job creations (5175)
Job search strategy (2850)
Kansas (100)
Layoffs (475)
Legal (10022)
Lung cancer (139)
Manufacturing (133)
Maryland (484)
Massachusetts (1972)
Medical device (14306)
Medtech (14311)
Mergers & acquisitions (22007)
Metabolic disorders (344)
Michigan (148)
Minnesota (253)
Neuroscience (1473)
New Jersey (703)
New York (707)
NextGen Class of 2024 (7625)
Non-profit (5056)
North Carolina (744)
Northern California (958)
Obesity (207)
Ohio (121)
Opinion (235)
Patents (89)
Pennsylvania (654)
People (63845)
Pharmaceutical (133)
Phase I (21720)
Phase II (30697)
Phase III (23206)
Pipeline (145)
Podcasts (79)
Postmarket research (3536)
Preclinical (9799)
Radiopharmaceuticals (252)
Rare diseases (167)
Real estate (7366)
Regulatory (25715)
Research institute (2636)
Resumes & cover letters (646)
South America (1647)
Southern California (896)
Startups (4274)
Texas (326)
United States (10548)
Vaccines (591)
Washington State (305)
Weight loss (185)
Date
Today (115)
Last 7 days (687)
Last 30 days (2780)
Last 365 days (39463)
2024 (29817)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 826,152 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
October 7, 2024
·
13 min read
Press Releases
CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant
October 7, 2024
·
7 min read
Press Releases
ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications
October 7, 2024
·
7 min read
Press Releases
Intellia Therapeutics Announces Initiation of HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
October 7, 2024
·
7 min read
Press Releases
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
October 7, 2024
·
5 min read
Press Releases
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
October 7, 2024
·
5 min read
Press Releases
IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
October 7, 2024
·
3 min read
Press Releases
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024
October 7, 2024
·
1 min read
Press Releases
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
October 7, 2024
·
7 min read
Press Releases
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
October 7, 2024
·
3 min read
1 of 82,616
Next
